Castle Biosciences Q1 2025 10-Q Filed
Ticker: CSTL · Form: 10-Q · Filed: May 5, 2025 · CIK: 1447362
| Field | Detail |
|---|---|
| Company | Castle Biosciences Inc (CSTL) |
| Form Type | 10-Q |
| Filed Date | May 5, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, reporting
TL;DR
Castle Biosciences Q1 2025 10-Q is in. Financials and biz updates out.
AI Summary
Castle Biosciences Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial figures and business segment information are presented, reflecting the company's ongoing activities in the medical diagnostics sector.
Why It Matters
This filing provides investors with the latest financial snapshot of Castle Biosciences, crucial for understanding the company's performance and outlook in the medical diagnostics market.
Risk Assessment
Risk Level: medium — 10-Q filings are standard financial reports, but the specific financial health and market position of Castle Biosciences could introduce medium risk.
Key Players & Entities
- Castle Biosciences Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250505 (date) — Filing date
- 001-38984 (other) — SEC File Number
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 5, 2025.
What is the company's SEC File Number?
The company's SEC File Number is 001-38984.
What is the fiscal year end for Castle Biosciences Inc.?
The fiscal year end for Castle Biosciences Inc. is December 31.
What is the business address of Castle Biosciences Inc.?
The business address is 505 S FRIENDSWOOD DRIVE, SUITE 401, FRIENDSWOOD, TX 77546.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 5, 2025 regarding CASTLE BIOSCIENCES INC (CSTL).